CSIMarket
 


Cytrx Corp  (CYTR)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Cytrx's Quick Ratio for Trailing Twelve Months Period

CYTR's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth



CYTR Quick Ratio for Trailing Twelve Months Period

(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
Y / Y Current Liabilities Growth -24.31 % -91.67 % -89.54 % -91.51 % -89.78 %
Y / Y Cash & cash equivalent Growth -24.94 % -46.8 % -42.87 % -43.22 % -46.37 %
Quick Ratio for Trailing Twelve Months Period 11.18 10.96 5.73 3.91 2.32
Total Ranking # 157 # 192 # 263 # #
Seq. Current Liabilities Growth 139.27 % -35.29 % -44.69 % -11.62 % -73.66 %
Seq. Cash & cash equivalent Growth -4.45 % -3.36 % -6.18 % -13.36 % -32.28 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Current Liabilities decreased faster than Cytrx's average Cash & cash equivalent, this led to increase in in Cytrx's Quick Ratio for Trailing Twelve Months Period to 11.18, Quick Ratio for Trailing Twelve Months Period remained below Cytrx Corp average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Drugs industry 19 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Cytrx. While Quick Ratio for Trailing Twelve Months Period overall ranking has improved so far to 157, from total ranking in previous quarter at 192.

What is Quick Ratio?
Learn more about CYTR
Quick Ratio CYTR in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 20
Sector # 64
S&P 500 # 153


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
11.18 9.29 5.73
(Sep 30 2019)   (Mar 31 2019)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2019, within Biotechnology & Drugs Industry Quick Ratio for Trailing Twelve Months Period
Eidos Therapeutics, Inc.  29.02 
Adverum Biotechnologies, Inc.  23.74 
G1 Therapeutics, Inc.  21.25 
Catalyst Biosciences, Inc.  18.32 
Iovance Biotherapeutics, inc.  17.86 
Voyager Therapeutics, Inc.  17.70 
Acceleron Pharma Inc  17.27 
Neoleukin Therapeutics, Inc.  16.01 
Regenxbio Inc.  15.67 
Audentes Therapeutics, inc.  15.55 
Homology Medicines, Inc.  14.69 
Casi Pharmaceuticals, Inc.  14.03 
Evelo Biosciences, Inc.  13.68 
Aerpio Pharmaceuticals, Inc.  13.68 
Fennec Pharmaceuticals Inc.  13.40 
Myokardia Inc  12.50 
Atara Biotherapeutics, Inc.  12.39 
Crispr Therapeutics Ag  11.69 
Pulse Biosciences, Inc.  11.59 
Urogen Pharma Ltd.  11.50 
Denali Therapeutics Inc.  11.40 
Organovo Holdings, Inc.  11.38 
Alder Biopharmaceuticals Inc  11.23 
Protokinetix, Inc.  10.98 
Lixte Biotechnology Holdings, Inc.  10.66 
Arcus Biosciences, Inc.  10.49 
Unity Biotechnology, Inc.  10.20 
Assembly Biosciences, inc.  10.18 
Scpharmaceuticals Inc.  10.15 
Fulgent Genetics, Inc.  10.10 


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TRDP's Profile

Stock Price

TRDP's Financials

Business Description

Fundamentals

Charts & Quotes

TRDP's News

Suppliers

TRDP's Competitors

Customers & Markets

Economic Indicators

TRDP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071